2026 – IP Group plc

Search in site

2022 data tab

Sector

Company name

Date

Title

07 Jan 2026

Pulmocide

Pulmocide announces termination of Opera-T Phase 3 study with Opelconazole

07 Jan 2026

Oxford Quantum Circuits Limited

OQC Appoints Darko Stojkovic as Chief Operating Officer to Strengthen Global Leadership and Operational Scale-Up

06 Jan 2026

Iksuda Therapeutics Ltd

Iksuda to present preliminary analysis of oesophageal cancer data from Phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium

Load more